• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Evidence-based supportive therapy for bronchiolitis varies significantly between hospitals

byKate AndersonandLeah Carr, MD
November 28, 2017
in Emergency, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Less than 75% of study infants hospitalized with acute bronchiolitis received the current recommended treatment, evidence-based supportive therapies (EBST), with significant variation between site of hospitalization.

2. Infants with apnea and dehydration more likely to received EBST, while those with chest retractions and dehydration were more likely to receive nonrecommended pharmacotherapies and chest radiographies, respectively.

Evidence Level: 2 (Good)

Study Rundown: Current guidelines support the use of EBST (defined as intravenous [IV] or nasogastric [NG] hydration, oxygen, and airway support) for the management of bronchiolitis, the most common reason for infant hospitalization. Studies from inpatient populations show an increase in hospitalization rates of children with more mild disease, and many children continue to receive pharmacotherapy and chest radiographies even though these measures are not routinely recommended. Researchers in this study analyzed data from 6 pediatric emergency research networks in 8 countries to determine the intersite and internetwork variation in infants hospitalized with a diagnosis of bronchiolitis who received at least 1 EBST during their ED visit or within 6 hours of their inpatient stay. They also looked at variation in use of chest radiographies (CXR) and nonrecommended pharmacotherapies. Results indicated that about 70% of hospitalized patients studied received ≥ 1 EBST, and that rates varied significantly by site but not network.  Overall, apnea and dehydration were the highest predictors of EBST use. CXR and pharmacotherapy use varied by site and by network, with highest rates of pharmacotherapy use in Spain/Portugal, and highest rates of CXR in the United States and Canada. This study reviewed data from tertiary care pediatric EDs which may limit its generalizability. Results from this study suggest the need for increased education and quality improvement strategies to encourage providers to follow recommended best practices and reduce unnecessary resource use when managing acute bronchiolitis in infants.

Click to read the study, published today in Pediatrics

Relevant reading: Variation in the management of infants hospitalized for bronchiolitis persists after the 2006 American Academy of Pediatrics bronchiolitis guidelines

RELATED REPORTS

Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients

#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection

#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis

In-depth [retrospective cohort]: This study enrolled previously healthy children <12 months old diagnosed with a first episode of bronchiolitis at 38 EDs in 8 countries during 2013. A total of 3725 patients (mean age 4.5 months, 61.1% male, 39.4% hospitalized) were included in this study which looked at rates of hospitalization with EBST, hospitalization without EBST, or discharge directly from the ED. Use of EBST was defined as hospitalization plus 1) IV or NG fluids, 2) supplemental oxygen, or 3) airway support administered during ED stay or within 6 hours of admission. Results indicated that 69.8% of hospitalized infants received ≥ 1 EBST, with rates ranging per site from 6.1% to 99.0% (median 23.4%; 95%CI 17.9%-28.3%, p < .001). Highest rates were seen among infants with apnea (OR 3.40, 95%CI 2.40-4.91) and dehydration (OR 3.22, 95%CI 2.31-4.35). No significant association was found between EBST use and network, however use of pharmacotherapy and CXR varied significantly by site (p < .001 for both) and network (p < .001 for pharmacotherapy and p = .002 for CXR). Pharmacotherapy use ranged from 2% to 79% between sites (median 24.5%; 95%CI 12.1%–40.3%) with higher odds found in Spain/Portugal, and among children with chest retractions (OR 22.7, 95%CI: 4.5–111.0 and OR 2.2, 95%CI 1.7–3.0, respectively). CXR performance ranged from 1.6% to 80.8% between sites (median 22.4%, 95%CI 13.0%–25.2%) with higher odds found in the US and Canada (OR 4.9, 95%CI 2.0–12.2 and OR 4.9, 95%CI 1.9–12.6, respectively) and among children with dehydration (OR 2.1, 95% CI1.5–2.9).

 Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: bronchiolitis
Previous Post

Tezacaftor-ivacaftor improves pulmonary function in cystic fibrosis patients: The EVOLVE trial

Next Post

2 Minute Medicine Rewind November 27, 2017

RelatedReports

RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Pharma

Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients

February 24, 2025
#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection
StudyGraphics

#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection

October 7, 2024
#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis
StudyGraphics

#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis

July 22, 2024
High error rate among parents measuring liquid medications
Infectious Disease

Respiratory syncytial virus disproportionately affects pre-term infants over term infants

April 25, 2024
Next Post
Pre-operative transcranial magnetic stimulation useful for language mapping

2 Minute Medicine Rewind November 27, 2017

AAP supports mindfulness of children’s media consumption

Surgeons from Massachusetts General Hospital Express Support for Research on Firearm Violence 

Rapid genetic testing useful for diagnosis of critically ill children

Extremely premature children have worse cognitive outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Oral vancomycin may be effective for pouchitis in inflammatory bowel disease
  • Inebilizumab improves outcome in patients generalized myasthenia gravis
  • Medbridge turns any phone into a motion-capture coach for at-home rehab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.